2018
DOI: 10.15419/bmrat.v5i5.442
|View full text |Cite
|
Sign up to set email alerts
|

Prebiotic prophylaxis of ventilator-associated pneumonia: A randomized clinical trial

Abstract: Introduction: There is evidence of the curing effects of prebiotics in promoting growth of bifid bacterium in the digestive system and the central role of bacteria colonization in the pathogenesis of ventilator-associated pneumonia (VAP). The purpose of this study was to evaluate the effects of administration of a prebiotic, namely fenugreek seeds, on VAP prevention and clinical outcomes in critically ill patients. Methods: In this study, 60 mechanically ventilated patients were randomly divided into 2 g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 19 publications
0
5
0
Order By: Relevance
“…Five studies also mentioned acid-suppression therapy using a proton pump inhibitor or H 2 antagonist. 8,19,21,27,30 Most studies diagnosed VAP on the basis of the American College of Chest Physician clinical criteria, mainly on imaging suggestive of pneumonia, body temperature, number of white blood cells, a purulent tracheal aspirate, and positive culture of tracheal aspirates occurring after 48 hours of MV, but the criteria for each study were nuanced. Six studies evaluated the safety of probiotics, and none found the presence of adverse reactions with probiotic use.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Five studies also mentioned acid-suppression therapy using a proton pump inhibitor or H 2 antagonist. 8,19,21,27,30 Most studies diagnosed VAP on the basis of the American College of Chest Physician clinical criteria, mainly on imaging suggestive of pneumonia, body temperature, number of white blood cells, a purulent tracheal aspirate, and positive culture of tracheal aspirates occurring after 48 hours of MV, but the criteria for each study were nuanced. Six studies evaluated the safety of probiotics, and none found the presence of adverse reactions with probiotic use.…”
Section: Resultsmentioning
confidence: 99%
“…The basic information of each study is shown in Table 1, which cumulatively have a publication range of 2006 to 2019. 8,[19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37] These studies included a total of 2428 patients (1201 probiotics and 1227 controls) who received MV from 13 countries in Europe, the United States, Australia, and Asia and consist of 13 single-center and 7 multicenter studies. In most studies, probiotics were administered by nasogastric tube or through oral administration; however, a few used the administration of a slurry to the oropharynx.…”
Section: Study Characteristicsmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of these therapies to prevent VAP remains highly controversial. Previous randomized controlled trials (RCTs) (14,(34)(35)(36)(37) and meta-analyses (38)(39)(40)(41)(42) based on high-quality RCTs suggested that probiotics, prebiotics, and synbiotics are associated with VAP prevention. Promising data seemed to support that probiotic or prebiotic supplementation is a strategy for preventing VAP.…”
Section: Controversy Of the Interventionmentioning
confidence: 99%
“…Numerous studies have shown that probiotic administration in critical care patients has many positive effects, such as preventing infections, MODS, VAP, and ICU-associated diarrhea. [14][15][16][17][18][19] Recent meta-analyses and reviews have evaluated the effect of probiotics on clinical parameters in mechanically ventilated patients. However, their results are controversial, which have led to inconsistent conclusions about the role of probiotics in critical illness.…”
Section: Introductionmentioning
confidence: 99%